EUVIMEDEUVIMED entdecken
Multizentrische Studie

Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance

Alexandra Lebedeva, Ekaterina Belova iD, Alexandra Kavun, Anastasiia Taraskina, Michele Bartoletti, Ivan Bièche, Giuseppe Curigliano, Célia Dupain, Alejandro Rios-Hoyo, Maud Kamal, Claudio Luchini, Stanislav Poyarkov und 4 weitere

Molecular Diagnosis & Therapy · 2025

DOI: 10.1007/s40291-024-00748-4 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Molecular Diagnosis & Therapy, 2025. Verfasst von Alexandra Lebedeva und 15 weiteren Autor:innen. Beteiligte Einrichtung: OncoAtlas LLC, Leninsky Ave, 1/4A, Moscow, 119049, Russia. lebedeva@oncoatlas.ru. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neoplasms, Molecular Targeted Therapy, Antineoplastic Agents. Die Arbeit nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorNeoplasmsMolecular Targeted TherapyAntineoplastic AgentsHumansPrecision MedicineObserver VariationMedical OncologyEurope

Substanzen

Biomarkers, TumorAntineoplastic Agents

Autor:innen und Institutionen

  • OncoAtlas LLC, Leninsky Ave, 1/4A, Moscow, 119049, Russia. lebedeva@oncoatlas.ru.
  • Laboratory of Applied Genomic Technologies, Institute of Personalized Oncology, Sechenov First Moscow State Medical University, Moscow, Russia. lebedeva@oncoatlas.ru.
  • OncoAtlas LLC, Leninsky Ave, 1/4A, Moscow, 119049, Russia.
  • Laboratory of Applied Genomic Technologies, Institute of Personalized Oncology, Sechenov First Moscow State Medical University, Moscow, Russia.
  • Lomonosov Moscow State University, Moscow, Russia.
  • Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.

ORCID-Profile: Ekaterina Belova

Zitieren

APA

Lebedeva, A., Belova, E., Kavun, A., Taraskina, A., Bartoletti, M., Bièche, I., Curigliano, G., Dupain, C., Rios-Hoyo, A., Kamal, M., Luchini, C., Poyarkov, S., Le Tourneau, C., Veselovsky, E., Mileyko, V., & Ivanov, M. (2025). Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance. Molecular Diagnosis & Therapy. https://doi.org/10.1007/s40291-024-00748-4

Vancouver

Lebedeva A, Belova E, Kavun A, Taraskina A, Bartoletti M, Bièche I, et al. Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance. Molecular Diagnosis & Therapy. 2025. doi:10.1007/s40291-024-00748-4

BibTeX
@article{Lebedeva2025,
  author = {Lebedeva, Alexandra and Belova, Ekaterina and Kavun, Alexandra and Taraskina, Anastasiia and Bartoletti, Michele and Bièche, Ivan and Curigliano, Giuseppe and Dupain, Célia and Rios-Hoyo, Alejandro and Kamal, Maud and Luchini, Claudio and Poyarkov, Stanislav and Le Tourneau, Christophe and Veselovsky, Egor and Mileyko, Vladislav and Ivanov, Maxim},
  title = {Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance},
  journal = {Molecular Diagnosis & Therapy},
  year = {2025},
  doi = {10.1007/s40291-024-00748-4}
}
Kostenlos starten →